6550--Notice of Intent to Sole Source- Ortho vision analyzer to include reagents, service support and consumables
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Central Arkansas Veterans Health Care System (CAVHCS), supported by the Network Contracting Office (NCO) 16, intends to award a sole source Firm-Fixed-Price Blanket Purchase Agreement (BPA) to Quidelortho Sales Company, LLC. This agreement is for a brand name Ortho vision analyzer, including necessary reagents, service support, and consumables. Interested parties who disagree with this sole source action must submit a letter of interest by May 28, 2026, 10:00 AM CST.
Opportunity Details
CAVHCS requires an Ortho vision analyzer, reagents, service support, and consumables that are compatible with their existing government-owned ortho workstations immunohematology analyzer. Quidelortho Sales Company, LLC is identified as the only authorized provider for these specific analyzers, reagents, controls, consumables, and service support. The instrument automates in vitro immunohematology testing using ID-Micro Typing System (ID-MTS) gel card technology, handling functions like liquid pipetting, reagent handling, incubation, centrifugation, reaction grading, and data management.
Key consumables and reagents include various MTS gel cards, Affirrmagen, Resolve A/C/Surg, diluents, Ortho 7% BSA, single-use dilution trays and caps, Ortho Daily QC Simulated Whole Blood Control, MTS-ID Pipette Tips, Ortho Daily QC Kit, and Buffered Gel Cards.
Contract & Timeline
- Contract Type: Firm-Fixed-Price Blanket Purchase Agreement (BPA)
- Period of Performance: Awarded BPA with option periods not exceeding five (5) years or sixty (60) months.
- Anticipated Award Date: October 1, 2026.
- NAICS Code: 325413, In-Vitro Diagnostic Substance Manufacturing (Size Standard 1250).
- Procurement Method: Conducted under GSAR subpart 538.7104-3(b)(ii) - Soliciting from a single source.
Response Information
This is a Special Notice and not a request for competitive quotes. It is posted for informational purposes only, and the government does not anticipate receiving responses. However, firms that disagree with this sole source intent may submit a letter of interest demonstrating their technical capability to provide compatible products and service support without duplicating government costs. Responses must be emailed to Contracting Officer Anthony Marion (anthony.marion2@va.gov) by May 28, 2026, 10:00 AM CST. The subject line should be "36C25626Q0790 Notice of Intent". Questions or comments must be directed to the same email by May 20, 2026, 10:00 AM CST.
Additional Notes
Late responses may not be accepted. Only emailed responses will be considered. The information received will be used solely to determine whether to conduct a competitive procurement, which remains at the sole discretion of the Government.